ANN ARBOR, MI – Nov 23, 2020 – Ripple Science today announced that it has successfully completed the Service Organization Control (SOC) 2 Type 1 audit.  The audit was performed by A-LIGN, a leading cybersecurity, and privacy solutions provider that in the past three years has assisted more than 2,500 clients in 30 countries meet security and privacy milestones. A-LIGN affirms that Ripple Science’s information security practices, policies, procedures, and operations meet the SOC 2 standards for security, confidentiality, and privacy.

Ripple Science’s SOC 2 report verifies the existence of internal controls that are designed and implemented to meet the requirements for the security, confidentiality, and privacy principles set forth in the Trust Services Principles and Criteria. The SOC 2 report provides a thorough review of how Ripple Science’s internal controls affect the security of the systems it uses to process users’ data and the confidentiality and privacy of the information processed by these systems. Independent validation of security controls is preferred by Clinical Researchers.

Chief Technology Officer Nancy Benovich Gilby shared, “Early on we identified SOC 2 compliance as core to the product and critical to Ripple Science’s desire to address the needs of larger research organizations. I am pleased that the team achieved this milestone on schedule.”

“SOC 2 compliance required significant investment and deepens the moat that protects our first-mover advantage providing an innovative solution that accelerates and automates the clinical trial patient journey,” added Peter Falzon, Ripple Science President and CEO.

As part of the SOC 2 work, HIPAA HITECH compliance was also attested. In addition to SOC 2 Compliance, Ripple Science continues to add additional layers of security and compliance to its platform.

About Ripple Science: Ripple Science aims to reduce clinical trial failures by 50% by adapting sales and marketing automation to accelerate participant recruitment and boost retention.  Additional benefits come from leveraging recruitment and retention data in Ripple to measure what matters and provide actionable insights powered by data science. Ripple is the market-leading SaaS platform used by public and private research organizations in order to provide clinical trial participants a truly great experience across more than 485 studies with over 1 million participant events tracked.

To learn more, please visit: https://www.ripplescience.com 

Media Contact